In breast cancer, palmitoylated proteins in tumor EVs can act as TLR2 ligands leading to upregulation of proinflammatory cytokines and chemokines including CCL2, IL-6 and GCSF in macrophages (52). This evidence concerns the gene CCL2 and neoplasm.